A new cyclic compound [(2S,3′S)‐2‐(2′‐oxo‐3′‐methylpiperazin‐1′‐yl)‐propanoic acid] obtained using (2S,7S)‐2,7‐dimethyl‐3,6‐diazaoctanedioic acid as a starting material was derived from N‐t‐butyloxycarbonyl‐(2S,3′S)‐2‐(2′‐oxo‐3′‐methylpiperazin‐1′‐yl)‐propanoic acid in order to determine the molecular structure by X‐ray crystal analysis. Two new macrocyclic peptides were prepared using the above cyclic compound and sarcosine as peptide units.
No takes yet. Share an insight, caveat, or question.
Yamashita et al. (1989) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: